Johnson D M, Geys R, Lissens J, Guns P J
Bio-Plus Safety Pharmacology, Vlasmeer 5/0003, B-2400 Mol, Belgium.
J Pharmacol Toxicol Methods. 2012 Sep;66(2):152-9. doi: 10.1016/j.vascn.2012.07.002. Epub 2012 Jul 17.
Evaluation of drug-related effects on cardiovascular function is part of the core battery described in the ICH S7A guideline. Anesthetized guinea-pigs are excellent models for the evaluation of drug-induced prolongation of ventricular repolarization; however less information is available regarding other cardio-hemodynamic parameters in this model. The current study aimed to document cardio-hemodynamic responses in anesthetized guinea-pigs after administration of a number of reference drugs with known pharmacological actions.
Experiments were carried out in closed chest pentobarbital anesthetized female guinea-pigs. Compounds were administered intravenously while arterial blood pressure, left ventricular pressure (LVP) and the electrocardiogram were measured continuously. The rate of LVP contraction (LV dP/dt(max)) was used to evaluate cardiac performance; and was compared to the QA interval; which has previously been proposed as an indirect measurement of cardiac function.
Baseline values for heart rate and blood pressure were lower in anesthetized animals compared to literature data of conscious guinea-pigs. Heart rate increased after administration of adrenaline, isoprenaline and salbutamol, but not after L-phenylephrine. Verapamil and amiodarone decreased heart rate and blood pressure. Zatebradine infusion led to a decrease in heart rate with minimal effects on blood pressure. Sodium nitroprusside (SNP) caused a reduction in mean blood pressure at higher doses followed by reflex tachycardia. Both adrenaline and L-phenylephrine increased arterial blood pressure. Furthermore, adrenaline, isoprenaline and salbutamol increased LV dP/dt(max) and decreased the QA interval. L-phenylephrine increased LV dP/dt(max), but transiently prolonged the QA interval. Both verapamil and amiodarone decreased LV dP/dt(max) and prolonged the QA interval, whereas zatebradine did not affect this parameter.
In addition to its utility for the assessment of test compounds on ventricular repolarization the pentobarbital anesthetized guinea-pig model shows promise for early stage cardio-hemodynamic screening. Furthermore, the QA interval shows potential for prediction of adverse effects on cardiac contractility.
评估药物对心血管功能的相关影响是国际人用药品注册技术协调会(ICH)S7A指南中所述核心试验的一部分。麻醉后的豚鼠是评估药物诱导的心室复极延长的优秀模型;然而,关于该模型中其他心脏血流动力学参数的信息较少。本研究旨在记录给予多种具有已知药理作用的参考药物后麻醉豚鼠的心脏血流动力学反应。
实验在戊巴比妥麻醉的闭胸雌性豚鼠身上进行。静脉注射化合物,同时连续测量动脉血压、左心室压力(LVP)和心电图。左心室压力收缩速率(LV dP/dt(max))用于评估心脏功能,并与QA间期进行比较;此前已有人提出QA间期可作为心脏功能的间接测量指标。
与清醒豚鼠的文献数据相比,麻醉动物的心率和血压基线值较低。静脉注射肾上腺素、异丙肾上腺素和沙丁胺醇后心率增加,但注射去氧肾上腺素后心率未增加。维拉帕米和胺碘酮可降低心率和血压。静脉输注扎替雷定可导致心率降低,对血压影响极小。硝普钠(SNP)在高剂量时可导致平均血压降低,随后出现反射性心动过速。肾上腺素和去氧肾上腺素均可升高动脉血压。此外,肾上腺素、异丙肾上腺素和沙丁胺醇可增加LV dP/dt(max)并缩短QA间期。去氧肾上腺素增加LV dP/dt(max),但短暂延长QA间期。维拉帕米和胺碘酮均可降低LV dP/dt(max)并延长QA间期,而扎替雷定不影响该参数。
除了可用于评估受试化合物对心室复极的影响外,戊巴比妥麻醉的豚鼠模型在早期心脏血流动力学筛查方面也显示出前景。此外,QA间期在预测对心脏收缩性的不良反应方面具有潜力。